Implications of Obesity for Drug Therapy: Limitations and Challenges

Does Hepatic Steatosis Affect Drug Metabolizing Enzymes in the Liver?

(2011) Christa Buechler et al.   CURRENT DRUG METABOLISM

Availability of information for dosing injectable medications in underweight or obese patients

(2010) K. A. Jacques et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Effect of Obesity on the Pharmacokinetics of Drugs in Humans

(2010) Michael J. Hanley et al.   CLINICAL PHARMACOKINETICS

BMI, pharmacokinetics, and OCP failure

(2010) Ganesh Cherala et al.   CONTRACEPTION

Metabolism and pharmacokinetics of contraceptive steroids in obese women: a review

(2010) Alison B. Edelman et al.   CONTRACEPTION

Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women

(2010) Carolyn L. Westhoff et al.   CONTRACEPTION

EMAS position statement: Managing obese postmenopausal women

(2010) Irene Lambrinoudaki et al.   MATURITAS

Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5

(2010) Jang Hyun Choi et al.   NATURE

Ovarian Suppression in Normal-Weight and Obese Women During Oral Contraceptive Use

(2010) Carolyn L. Westhoff et al.   OBSTETRICS AND GYNECOLOGY

Effectiveness of Oral Contraceptive Pills in a Large U.S. Cohort Comparing Progestogen and Regimen

(2010) Jürgen Dinger et al.   OBSTETRICS AND GYNECOLOGY

Drug disposition in obesity and protein–energy malnutrition

(2010) Joseph I. Boullata   PROCEEDINGS OF THE NUTRITION SOCIETY

The adverse effects of obesity on conception and implantation

(2010) Christopher J Brewer et al.   REPRODUCTION

Obesity in the Intensive Care Unit

(2009) Shyoko Honiden et al.   CLINICS IN CHEST MEDICINE

Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity

(2009) Alison B. Edelman et al.   CONTRACEPTION

Obesity and oral contraceptive pill failure

(2009) James Trussell et al.   CONTRACEPTION

Contraceptive considerations in obese women

(2009) Alison Edelman   CONTRACEPTION

Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes

(2009) C. Schmid et al.   DIABETOLOGIA

Lean body mass normalizes the effect of obesity on renal function

(2008) Sarayut Janmahasatian et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Response to “Influence of Lean Body Weight on Anticancer Drug Clearance”

(2008) PY Han et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Influence of Lean Body Weight on Anticancer Drug Clearance

(2008) RHJ Mathijssen et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics

(2007) B.J. Anderson et al.   Annual Review of Pharmacology and Toxicology